Elavil (amitriptyline) Treatment Report
Generic Name: Amitriptyline
What is Elavil?
Elavil, a brand name for amitriptyline, is a tricyclic antidepressant approved for the treatment of depression. Off label amitripyline is used for certain chronic and neuropathic (nerve) pain and for prevention of migraine headaches.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Pain | 17 |
|
|
|
3 | ||
| Depression | 8 | 0 | |||||
| Other | 8 | 0 | |||||
| Headaches | 3 |
|
1 | ||||
| Difficulty sleeping through night | 3 |
|
1 | ||||
| Insomnia | 2 |
|
1 |
Mouse over the table for more information
Side Effects
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
6 | 55% |
|
|
Side effects too severe
|
3 | 27% |
|
|
Other
|
2 | 18% |
|
|
Not indicated
|
2 | 18% |
|
|
Doctor's advice
|
1 | 9% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 6 patient evaluations
-
- sgtstardust
- Sex: M
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: moderate
- Swallowing: none
- Upper limb: none
- Walking: severe
- See profile
-
-
- sgtstardust
- since Sep 21, 2008
-
Efficacy
Major
for Pain
-
Side Effects
Mild
- Advice/Tips If you really want to sleep through the night in a major way, this is for you. I dropped it a few years back because I felt I was taxing my liver with too ma... See full evaluation
-
- galderson
- Sex: M
- Sensation: Moderate
- Overall: Mild
- Cognition: mild
- Vision: mild
- Speech: mild
- Swallowing: mild
- Upper limb: moderate
- Walking: moderate
- See profile
-
- galderson
- 50 mg daily
- since Oct 27, 2008
-
Efficacy
Major
for Insomnia
-
Side Effects
Moderate
- Advice/Tips could not stay awake for about 10 days when I first started med. See full evaluation
See all 6 patient evaluations
Report created on November 23, 2009.